99 related articles for article (PubMed ID: 38667272)
1. Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Incident Type 2 Diabetes Risk.
Tobias DK; Manning AK; Wessel J; Raghavan S; Westerman KE; Bick AG; Dicorpo D; Whitsel EA; Collins J; Correa A; Cupples LA; Dupuis J; Goodarzi MO; Guo X; Howard B; Lange LA; Liu S; Raffield LM; Reiner AP; Rich SS; Taylor KD; Tinker L; Wilson JG; Wu P; Carson AP; Vasan RS; Fornage M; Psaty BM; Kooperberg C; Rotter JI; Meigs J; Manson JE;
Diabetes Care; 2023 Nov; 46(11):1978-1985. PubMed ID: 37756531
[TBL] [Abstract][Full Text] [Related]
2. Aberrant activation of TCL1A promotes stem cell expansion in clonal haematopoiesis.
Weinstock JS; Gopakumar J; Burugula BB; Uddin MM; Jahn N; Belk JA; Bouzid H; Daniel B; Miao Z; Ly N; Mack TM; Luna SE; Prothro KP; Mitchell SR; Laurie CA; Broome JG; Taylor KD; Guo X; Sinner MF; von Falkenhausen AS; Kääb S; Shuldiner AR; O'Connell JR; Lewis JP; Boerwinkle E; Barnes KC; Chami N; Kenny EE; Loos RJF; Fornage M; Hou L; Lloyd-Jones DM; Redline S; Cade BE; Psaty BM; Bis JC; Brody JA; Silverman EK; Yun JH; Qiao D; Palmer ND; Freedman BI; Bowden DW; Cho MH; DeMeo DL; Vasan RS; Yanek LR; Becker LC; Kardia SLR; Peyser PA; He J; Rienstra M; Van der Harst P; Kaplan R; Heckbert SR; Smith NL; Wiggins KL; Arnett DK; Irvin MR; Tiwari H; Cutler MJ; Knight S; Muhlestein JB; Correa A; Raffield LM; Gao Y; de Andrade M; Rotter JI; Rich SS; Tracy RP; Konkle BA; Johnsen JM; Wheeler MM; Smith JG; Melander O; Nilsson PM; Custer BS; Duggirala R; Curran JE; Blangero J; McGarvey S; Williams LK; Xiao S; Yang M; Gu CC; Chen YI; Lee WJ; Marcus GM; Kane JP; Pullinger CR; Shoemaker MB; Darbar D; Roden DM; Albert C; Kooperberg C; Zhou Y; Manson JE; Desai P; Johnson AD; Mathias RA; ; Blackwell TW; Abecasis GR; Smith AV; Kang HM; Satpathy AT; Natarajan P; Kitzman JO; Whitsel EA; Reiner AP; Bick AG; Jaiswal S
Nature; 2023 Apr; 616(7958):755-763. PubMed ID: 37046083
[TBL] [Abstract][Full Text] [Related]
3. Solid Organ Transplant Recipients Exhibit More TET2-Mutant Clonal Hematopoiesis of Indeterminate Potential Not Driven by Increased Transplantation Risk.
Silver AJ; Vlasschaert C; Mack T; Sharber B; Xu Y; Bick AG; Pinson CW; Savona MR
Clin Cancer Res; 2024 Jun; 30(11):2475-2485. PubMed ID: 38551504
[TBL] [Abstract][Full Text] [Related]
4. Clonal hematopoiesis: Mutation-specific adaptation to environmental change.
Florez MA; Tran BT; Wathan TK; DeGregori J; Pietras EM; King KY
Cell Stem Cell; 2022 Jun; 29(6):882-904. PubMed ID: 35659875
[TBL] [Abstract][Full Text] [Related]
5. Clonal hematopoiesis associated with epigenetic aging and clinical outcomes.
Nachun D; Lu AT; Bick AG; Natarajan P; Weinstock J; Szeto MD; Kathiresan S; Abecasis G; Taylor KD; Guo X; Tracy R; Durda P; Liu Y; Johnson C; Rich SS; Van Den Berg D; Laurie C; Blackwell T; Papanicolaou GJ; Correa A; Raffield LM; Johnson AD; Murabito J; Manson JE; Desai P; Kooperberg C; Assimes TL; Levy D; Rotter JI; Reiner AP; Whitsel EA; Wilson JG; Horvath S; Jaiswal S;
Aging Cell; 2021 Jun; 20(6):e13366. PubMed ID: 34050697
[TBL] [Abstract][Full Text] [Related]
6. Clonal hematopoiesis of indeterminate potential is rare in pediatric patients undergoing autologous stem cell transplantation.
Kartal-Kaess M; Karow A; Bacher U; Pabst T; Joncourt R; Zweier C; Kuehni CE; Porret NA; Roessler J
Pediatr Hematol Oncol; 2024 Jun; ():1-10. PubMed ID: 38840569
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of clonal hematopoiesis in pediatric ADA-SCID gene therapy participants.
White SL; Lee TD; Toy T; Carroll JE; Polsky L; Campo Fernandez B; Davila A; Kohn DB; Chang VY
Blood Adv; 2022 Nov; 6(21):5732-5736. PubMed ID: 35914227
[TBL] [Abstract][Full Text] [Related]
8. Impact of Clonal Hematopoiesis-Associated Mutations in Phase I Patients Treated for Solid Tumors: An Analysis of the STING Trial.
Rodriguez J; Baldini C; Bayle A; Pages A; Danlos FX; Vasseur D; Rouleau E; Lacroix L; Alonso de Castro B; Goldschmidt V; Seknazi L; Hollebecque A; Michot JM; Champiat S; Marabelle A; Ouali K; Marzac C; Ponce S; Micol JB; Chaput N; Massard C; Italiano A
JCO Precis Oncol; 2024 May; 8():e2300631. PubMed ID: 38815178
[TBL] [Abstract][Full Text] [Related]
9. Impact of Cancer Therapy on Clonal Hematopoiesis Mutations and Subsequent Clinical Outcomes.
Nead KT; Kim T; Joo L; McDowell T; Wong J; Chan IC; Brock E; Zhao J; Xu T; Tang C; Lee CL; Abe JI; Bolton KL; Liao Z; Scheet P; Lin SH
Blood Adv; 2024 Jun; ():. PubMed ID: 38830141
[TBL] [Abstract][Full Text] [Related]
10. Single-cell profiling in multiple myeloma: insights, problems, and promises.
Samur MK; Szalat R; Munshi NC
Blood; 2023 Jul; 142(4):313-324. PubMed ID: 37196627
[TBL] [Abstract][Full Text] [Related]
11. Functional Dominance of CHIP-Mutated Hematopoietic Stem Cells in Patients Undergoing Autologous Transplantation.
Ortmann CA; Dorsheimer L; Abou-El-Ardat K; Hoffrichter J; Assmus B; Bonig H; Scholz A; Pfeifer H; Martin H; Schmid T; Brüne B; Scheich S; Steffen B; Riemann J; Hermann S; Dukat A; Bug G; Brandts CH; Wagner S; Serve H; Rieger MA
Cell Rep; 2019 May; 27(7):2022-2028.e3. PubMed ID: 31091442
[TBL] [Abstract][Full Text] [Related]
12. Clonal hematopoiesis and associated diseases: A review of recent findings.
Asada S; Kitamura T
Cancer Sci; 2021 Oct; 112(10):3962-3971. PubMed ID: 34328684
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic dysregulation of hematopoietic stem cells and preleukemic state.
Kunimoto H; Nakajima H
Int J Hematol; 2017 Jul; 106(1):34-44. PubMed ID: 28555413
[TBL] [Abstract][Full Text] [Related]
14. Single-Cell DNA Sequencing Reveals an Evolutionary Pattern of CHIP in Transplant Eligible Multiple Myeloma Patients.
Borsi E; Vigliotta I; Poletti A; Mazzocchetti G; Solli V; Zazzeroni L; Martello M; Armuzzi S; Taurisano B; Kanapari A; Pistis I; Zamagni E; Pantani L; Rocchi S; Mancuso K; Tacchetti P; Rizzello I; Rizzi S; Dan E; Sinigaglia B; Cavo M; Terragna C
Cells; 2024 Apr; 13(8):. PubMed ID: 38667272
[TBL] [Abstract][Full Text] [Related]
15. Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant.
Mouhieddine TH; Sperling AS; Redd R; Park J; Leventhal M; Gibson CJ; Manier S; Nassar AH; Capelletti M; Huynh D; Bustoros M; Sklavenitis-Pistofidis R; Tahri S; Hornburg K; Dumke H; Itani MM; Boehner CJ; Liu CJ; AlDubayan SH; Reardon B; Van Allen EM; Keats JJ; Stewart C; Mehr S; Auclair D; Schlossman RL; Munshi NC; Anderson KC; Steensma DP; Laubach JP; Richardson PG; Ritz J; Ebert BL; Soiffer RJ; Trippa L; Getz G; Neuberg DS; Ghobrial IM
Nat Commun; 2020 Jun; 11(1):2996. PubMed ID: 32533060
[TBL] [Abstract][Full Text] [Related]
16. Prevalence, mutational spectrum and clinical implications of clonal hematopoiesis of indeterminate potential in plasma cell dyscrasias.
Testa S; Kumar J; Goodell AJ; Zehnder JL; Alexander KM; Sidana S; Arai S; Witteles RM; Liedtke M
Semin Oncol; 2022 Dec; 49(6):465-475. PubMed ID: 36503855
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
